• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Marconi silence feeds rumors

Article

Rumors are the stuff of celebrity gossip, conspiracy theories, and UFOs. It can be argued that they have no place in healthcare. But the flap over the possible sale of Marconi Medical has laid that hope to rest. DI SCAN has remained mute on the

Rumors are the stuff of celebrity gossip, conspiracy theories, and UFOs. It can be argued that they have no place in healthcare. But the flap over the possible sale of Marconi Medical has laid that hope to rest. DI SCAN has remained mute on the topic since speculation first appeared on the heels of parent company Marconi PLC’s decision in mid-April to move Marconi Medical to its Capital division, which in the past has served as a kind of limbo for parts of the company being readied for sale. Marconi executives have refused comment to DI SCAN. The company has been similarly silent to other media, whose articles on the topic have appeared without statements from Marconi executives.

What Marconi seems not to fully understand is that the media, like nature, abhor a vacuum. Marconi’s silence has led some information outlets to let their imaginations run wild. The result has not always been favorable to Marconi. One well-respected publication described the company’s business as “ailing” and quoted sources that described the company as weakening.

My sources at Marconi and at the company’s suppliers confirm that Marconi Medical is not “ailing” but in fact is having a very good year. The company has focused on its most lucrative offerings, while finding ways to cut R&D costs and extend its range of products within select areas through corporate partnerships. The most recent is the deal with CTI PET Systems to supply PET scanners (see cover story).

Marconi’s strength is not going to be recognized, however, if the company refuses to address the sale issue. Just acknowledging the facts would provide the opportunity for Marconi to put its own spin on the story-to reassure corporate partners and customers. But corporate policy, I’m told, is to say nothing.

Meanwhile Marconi executives get roiled over what they see as misuse of media stories by some of their competitors. They lament that customers are being sent these articles. The nut of the problem, however, may be Marconi’s failure to tell its side of the story. In a world where perception can dictate reality, Marconi is playing a dangerous game, putting at risk equipment sales and critical alliances, as well as key personnel who might seek new employment in light of an uncertain future.

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.